These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 3528710

  • 1. [Autoantibodies in vitiligo. Clinical significance].
    Morgan M, Castells A, Ramírez A.
    Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
    Hertz KC, Gazze LA, Kirkpatrick CH, Katz SI.
    N Engl J Med; 1977 Sep 22; 297(12):634-7. PubMed ID: 331108
    [Abstract] [Full Text] [Related]

  • 3. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
    Betterle C, Caretto A, Pedini B, Rigon F, Bertoli P, Peserico A.
    Arch Dermatol; 1992 Jan 22; 128(1):123-4. PubMed ID: 1739282
    [No Abstract] [Full Text] [Related]

  • 4. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O, Shoenfeld Y, Baharav E, Zigelman R, Fishman P.
    Hum Antibodies Hybridomas; 1996 Jan 22; 7(4):151-6. PubMed ID: 9140726
    [Abstract] [Full Text] [Related]

  • 5. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
    Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM.
    BMC Dermatol; 2006 Mar 10; 6():3. PubMed ID: 16526964
    [Abstract] [Full Text] [Related]

  • 6. [Melanocyte antibodies in idiopathic vitiligo (author's transl)].
    Höfs T, Zugehör M, Morenz J.
    Dermatol Monatsschr; 1981 Nov 10; 167(11):685-92. PubMed ID: 7044847
    [No Abstract] [Full Text] [Related]

  • 7. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
    Peserico A, Rigon F, Semenzato G, Caretto A, Pasini CV, Betterle C.
    Arch Dermatol; 1981 Nov 10; 117(11):751-2. PubMed ID: 7316541
    [No Abstract] [Full Text] [Related]

  • 8. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A, Brito GJ, Reyes-Izquierdo P, Pérez-Romano B, Sánchez-Sosa S.
    J Autoimmun; 2007 Dec 10; 29(4):281-6. PubMed ID: 17888626
    [Abstract] [Full Text] [Related]

  • 9. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
    Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP.
    Autoimmun Rev; 2007 Jan 10; 6(3):138-42. PubMed ID: 17289548
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis.
    Howanitz N, Nordlund JL, Lerner AB, Bystryn JC.
    Arch Dermatol; 1981 Nov 10; 117(11):705-8. PubMed ID: 7316530
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the immune system in 55 Iranian patients with vitiligo.
    Farrokhi S, Hojjat-Farsangi M, Noohpisheh MK, Tahmasbi R, Rezaei N.
    J Eur Acad Dermatol Venereol; 2005 Nov 10; 19(6):706-11. PubMed ID: 16268875
    [Abstract] [Full Text] [Related]

  • 12. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
    al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie JA, Goudie RB.
    J Pathol; 1993 Feb 10; 169(2):203-6. PubMed ID: 8095298
    [Abstract] [Full Text] [Related]

  • 13. [Symptomatic tapetoretinal degeneration in pigment disorders of the skin: approaches to understanding the pathomechanism and therapy].
    Krastel H, Anton-Lamprecht I, Alexandridis E, Tilgen W.
    Fortschr Ophthalmol; 1985 Feb 10; 82(6):562-70. PubMed ID: 4093108
    [No Abstract] [Full Text] [Related]

  • 14. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
    Presser HJ, Morenz J, Höfs T, Zugehör M, Kühne KH, Brödemann M.
    Dermatol Monatsschr; 1987 Feb 10; 173(8):441-5. PubMed ID: 3311840
    [No Abstract] [Full Text] [Related]

  • 15. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N, Gavalas NG, Weetman AP, Kemp EH.
    J Eur Acad Dermatol Venereol; 2007 Aug 10; 21(7):865-76. PubMed ID: 17658994
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study.
    Korkij W, Soltani K, Simjee S, Marcincin PG, Chuang TY.
    J Cutan Pathol; 1984 Dec 10; 11(6):522-30. PubMed ID: 6520261
    [Abstract] [Full Text] [Related]

  • 17. Vitiligo and antibodies to melanocytes.
    Bystryn JC, Pfeffer S.
    Prog Clin Biol Res; 1988 Dec 10; 256():195-206. PubMed ID: 3285350
    [Abstract] [Full Text] [Related]

  • 18. Immune mechanisms in vitiligo.
    Bystryn JC.
    Immunol Ser; 1989 Dec 10; 46():447-73. PubMed ID: 2488866
    [Abstract] [Full Text] [Related]

  • 19. Immune-mediated subepithelial blistering diseases of the mucous membranes. Improving the detection of circulating autoantibodies by the use of concentrated serum samples.
    Korman NJ, Watson RD.
    Arch Dermatol; 1996 Oct 10; 132(10):1194-8. PubMed ID: 8859030
    [Abstract] [Full Text] [Related]

  • 20. Autoimmunity and multiple endocrine abnormalities.
    Forcier RJ, McIntyre OR, Frey WG, Andrada JA, Streiff RR.
    Arch Intern Med; 1972 Apr 10; 129(4):638-41. PubMed ID: 5067225
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.